Epratuzumab (LymphoCide)

Mechanism of action

Anti-CD22 antibody

Preliminary data

Acute lymphocytic leukemia

1. SWOG S0910: Advani AS, McDonough S, Coutre S, Wood B, Radich J, Mims M, O'Donnell M, Elkins S, Becker M, Othus M, Appelbaum FR. SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia. Br J Haematol. 2014 May;165(4):504-9. Epub 2014 Mar 3. PubMed link to original article

Also known as

• Code name: AMG 412, hLL2
• Brand name: LymphoCide